EMFAT
IMVT icon

Emerald Mutual Fund Advisers Trust’s Immunovant IMVT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-156,097
Closed -$3.87M – 219
2024
Q4 		$3.87M Sell
156,097
-27,524
-15% -$781K 0.24% 107
2024
Q3 		$5.24M Sell
183,621
-17,466
-9% -$515K 0.27% 104
2024
Q2 		$5.31M Hold
201,087
– – 0.28% 100
2024
Q1 		$6.5M Sell
201,087
-3,312
-2% -$121K 0.34% 97
2023
Q4 		$8.61M Buy
+204,399
New +$7.52M 0.46% 87
2021
Q1 		– Sell
-547,314
Closed -$25.3M – 226
2020
Q4 		$25.3M Buy
547,314
+44,441
+9% +$2.05M 0.88% 42
2020
Q3 		$17.7M Buy
+502,873
New +$15.1M 0.78% 51

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's IMVT Position: Q1 2025 in Review

Emerald Mutual Fund Advisers Trust sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 156,097 shares — an estimated $3.87M sold.

Emerald Mutual Fund Advisers Trust first reported a position in IMVT in Q3 2020 and held it in 7 quarters. The position peaked at $25.3M in Q4 2020. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Emerald Mutual Fund Advisers Trust reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 156,097 Immunovant shares in Q1 2025, an estimated $3.87M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Immunovant in Q3 2020 and held it in 7 quarters.
  • Emerald Mutual Fund Advisers Trust's Immunovant position peaked at $25.3M in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2025, filed 1 May 2025.